Neumora Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:NMRA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
17 Feb 26	SellUS$34,459	Paul Berns	Individual	9,819	US$3.51
17 Feb 26	SellUS$21,917	Daljit Aurora	Individual	6,165	US$3.56
17 Feb 26	SellUS$21,093	Joshua Pinto	Individual	5,967	US$3.54
27 Oct 25	BuyUS$4,999,977	ARCH Venture Fund XII, L.P.	Company	1,915,700	US$2.61

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NMRA?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	638,784	0.345%
Individual Insiders	8,267,582	4.46%
VC/PE Firms	27,800,931	15%
Public Companies	35,368,653	19.1%
General Public	43,404,961	23.4%
Institutions	69,803,333	37.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 69.51% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.1%	Amgen Inc.	35,368,653	US$53.4m	0%	no data
15%	Arch Venture Partners, L.P.	27,800,931	US$42.0m	0%	3.7%
4.59%	Artal Group S.A.	8,497,822	US$12.8m	35.1%	0.24%
4.16%	Paul Berns	7,708,851	US$11.6m	0.43%	no data
3.29%	SoftBank Group Corp.	6,090,301	US$9.2m	-5.28%	no data
2.75%	Perceptive Advisors LLC	5,104,097	US$7.7m	0%	0.15%
2.41%	MIC Capital Management UK LLP	4,460,700	US$6.7m	0%	1.57%
2.1%	Vanguard Capital Management, LLC	3,891,893	US$5.9m	0%	no data
1.88%	Impresa Management LLC	3,487,100	US$5.3m	0%	2.77%
1.79%	Wellcome Trust, Investment Division	3,309,123	US$5.0m	0%	0.05%
1.49%	Millennium Management LLC	2,754,854	US$4.2m	-23.8%	no data
1.38%	ICONIQ Capital, LLC	2,559,090	US$3.9m	0%	0.08%
1.15%	Lunate	2,124,143	US$3.2m	0%	1.98%
1.11%	BlackRock, Inc.	2,054,316	US$3.1m	1.45%	no data
1.1%	Two Sigma Investments, LP	2,036,692	US$3.1m	55.8%	no data
1%	Johnson & Johnson Innovation - JJDC, Inc.	1,849,445	US$2.8m	0%	0.39%
0.76%	Susquehanna International Group, LLP	1,400,560	US$2.1m	72.8%	no data
0.75%	Renaissance Technologies LLC	1,388,998	US$2.1m	-3.94%	no data
0.69%	Ikarian Capital, LLC	1,278,408	US$1.9m	0%	0.32%
0.65%	Marshall Wace LLP	1,195,310	US$1.8m	105%	no data
0.59%	Geode Capital Management, LLC	1,086,865	US$1.6m	8.28%	no data
0.54%	Adage Capital Management, L.P.	1,000,000	US$1.5m	0%	no data
0.44%	Silverarc Capital Management, LLC	818,156	US$1.2m	0%	0.16%
0.42%	Tudor Investment Corporation	771,418	US$1.2m	0%	0.01%
0.4%	Jane Street Group, LLC	747,665	US$1.1m	-33.8%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/22 14:35
End of Day Share Price	2026/06/18 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Neumora Therapeutics, Inc. is covered by 10 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yatin Suneja	Guggenheim Securities, LLC
Douglas Tsao	H.C. Wainwright & Co.
Tessa Romero	J.P. Morgan